Abstract
Get full access to this article
View all access options for this article.
References
1.Postmarketing Surveillance of Prescription Drugs . Office of Technology Assessment , Congress of the United States, November 1982 .
2.
Wardell
WM
Tsianco
MC
Anavekar
SN
: Postmarketing surveillance of new drugs: 1. Review of objectives and methodology . J Clin Pharm
1979 ; 19 :85 .